Drug
Nexavar
Nexavar: highest development phase Phase 3, developed by Bayer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nexavar (Sorafenib, BAY43-9006) NCT00692770 | Phase 3 | Carcinoma, Hepatocellular |
| Nexavar (Sorafenib, BAY43-9006) NCT00492986 | Phase 3 | Carcinoma, Renal Cell |
Latest
No recent events.
Follow Nexavar on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.